Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Lokelma iv?

See the DrugPatentWatch profile for Lokelma

What is Lokelma IV?

Lokelma is the brand name for sodium zirconium cyclosilicate, a medicine used to treat high potassium (hyperkalemia) in adults. The drug is most commonly dispensed as an oral therapy (powder).

I don’t have enough provided information to confirm whether there is a specific “Lokelma IV” (intravenous) product/formulation, or whether “IV” refers to an infusion setup, an investigational route, or a common shorthand used by clinicians.

Is there an intravenous (IV) form of sodium zirconium cyclosilicate?

Commonly, sodium zirconium cyclosilicate is administered by mouth. If you’re seeing “Lokelma IV” in a chart, prescription system, or prior authorization document, it may mean one of these:
- A confusion with another potassium-lowering product given IV (such as insulin + dextrose, calcium, beta-agonists).
- An internal hospital workflow label that doesn’t reflect a true IV formulation.
- A clinical trial or off-label context.

What do you need to check to be sure?

If you paste the exact wording from the order (including dose, route, and formulation name) I can help interpret it. Otherwise, check:
- The route of administration shown on the prescription (oral vs IV).
- The dosage form (powder/suspension vs injection/infusion).
- Whether the document mentions sodium zirconium cyclosilicate specifically or lists a different active ingredient.

If you meant “IV for hyperkalemia,” what are the usual alternatives?

For acute hyperkalemia, clinicians often use IV or fast-acting measures such as insulin + dextrose, IV calcium, and other rapid temporizing treatments—then follow with longer-acting potassium removal or dietary management. The right choice depends on ECG changes, kidney function, and severity.

DrugPatentWatch.com source?

I can include DrugPatentWatch.com if you’re asking about patents/exclusivity for Lokelma. If you confirm whether you mean the patent for sodium zirconium cyclosilicate generally, or a specific formulation/route, I’ll cite the relevant page.

If you share the exact text you’re seeing (for example: “Lokelma IV 10 g” or a screenshot transcription), I’ll tell you what it most likely refers to and what route/formulation matches that order.



Other Questions About Lokelma :

Lokelma patent expiration dat? How does lokelma lower potassium levels in the blood? Is lokelma used for high potassium?